Hearings to examine China's toll on older Americans' health, finances, and security

Defense Posture and Global ThreatsSenate Aging (Special) · June 17, 2026 · 119th Congress
The Senate Special Committee on Aging held this hearing to examine how the Chinese government and Chinese-linked criminal networks harm older Americans through fentanyl trafficking, pharmaceutical supply-chain dependence, financial scams, and data collection. Begins at ▶ 0:14:04
Transcript
Highlights

Title

China's impact on older Americans' health, finances, and data security

Purpose

The Senate Special Committee on Aging held this hearing to examine how the Chinese government and Chinese-linked criminal networks harm older Americans through fentanyl trafficking, pharmaceutical supply-chain dependence, financial scams, and data collection. Witnesses from the U.S.-China Economic and Security Review Commission testified on scam centers in Southeast Asia, China's dominance of generic drug ingredients, and risks from Chinese access to Americans' health and financial data. The hearing also previewed several bipartisan bills, including the Clear Labels Act and scam-related legislation. Begins at▶ 0:14:04

Who spoke

• Chair Rick Scott (R-FL)▶ 0:14:04: Opened by describing China as waging a strategic campaign against seniors through fentanyl, pharmaceutical dependence, and scams▶ 0:14:28; said China supplies over 90% of active pharmaceutical ingredients for U.S. generics and 87% of antibiotic imports▶ 0:15:24▶ 0:15:54; cited $5 billion lost by Americans over 60 to scams in 2024▶ 0:16:53; later questioned witnesses on fentanyl supply chains▶ 1:12:24, the Entity List▶ 1:16:54, 401(k) exposure to Chinese companies▶ 1:29:18, and closed by publicizing the committee's fraud hotline▶ 1:32:24.

• Sen. Kirsten Gillibrand (D-NY), Ranking Member▶ 0:20:08: Highlighted her bipartisan National Strategy for Combating Scams Act requiring an FBI-led government-wide strategy▶ 0:20:23; warned China is racing to dominate biotechnology within a few years▶ 0:22:41; later pressed witnesses on prioritizing supply chains and DFC financing tools▶ 0:57:18▶ 1:01:58, described creating Florida's Cyber Fraud Task Force as attorney general and cited $21 billion in 2025 cyber-enabled fraud losses▶ 1:06:58, and asked about AI's potential to counter scams▶ 1:24:02.

• Joshua Hodges, Commissioner, U.S.-China Economic and Security Review Commission▶ 0:23:48: Testified China is using below-cost pricing to eliminate Western producers of specialty chemicals used in IV treatments and implants, with no substitute within 10-15 years▶ 0:27:04; said Chinese components in the U.S. grid could pose remote-access risks to medical equipment▶ 0:28:34; said cartels, not Beijing's president, are believed to drive fentanyl trafficking▶ 1:13:10; said investing in Chinese firms is "absolutely not" the same as investing in South Korean firms given dual-use technology risk▶ 1:29:36.

• Leland Miller, Commissioner, U.S.-China Economic and Security Review Commission▶ 0:30:07: Described a data-dominance hearing showing Chinese law compels companies to hand data to the state on demand▶ 0:30:52; said scam centers occupy entire city blocks with implicit government approval▶ 0:47:21; said China's share of global pharmaceutical licensing deals has risen from 3-5% to over 40%▶ 1:17:45; warned retirees often unknowingly hold Chinese, sometimes sanctioned, companies in mutual funds with no transparency▶ 1:31:28.

• Catherine Price, Commissioner, U.S.-China Economic and Security Review Commission▶ 0:35:43: Said Americans reported $17.7 billion in online scam losses in 2025, a 29% increase, with nearly a quarter stolen from those over 60▶ 0:36:15; said Southeast Asian scam centers generated roughly $44 billion, about 44% of the host countries' combined GDP▶ 0:37:04; noted China's own scam losses fell 30% in 2024 as U.S. losses rose 40%▶ 0:38:28; said the committee is down two commissioners awaiting appointment▶ 1:23:38.

• Chris Slevin, Commissioner, U.S.-China Economic and Security Review Commission▶ 0:41:05: Said China is executing an integrated, state-directed strategy to dominate every stage of pharmaceutical production▶ 0:41:31; said the U.S. lacks reliable data on API import volumes and dependency▶ 0:44:00; recommended government purchasing power and CHIPS Act-style financing for domestic drug manufacturing▶ 0:44:30▶ 0:44:56; said the U.S. makes zero generic antibiotics domestically▶ 0:58:12.

• Sen. Tommy Tuberville (R-AL)▶ 0:46:36: Questioned witnesses on whether China can be trusted on drug safety▶ 0:46:36, the structure of scam operations▶ 0:47:05, and whether China is ahead in crypto▶ 0:49:36.

• Sen. Jon Husted (R-OH)▶ 0:51:13: Asked what would happen if China fully cut off pharmaceutical exports, calling it alarming▶ 0:51:38; argued the U.S. was "asleep at the wheel" letting China into the WTO and lost leverage on pharmaceuticals, rare earths, telecom, and ships▶ 0:55:11.

• Sen. Ashley Moody (R-FL)▶ 1:12:21: Briefly thanked the chairman during the discussion of scam manpower▶ 1:12:21.

Key moments

• Chair Scott said over 90% of prescriptions filled in America are generics whose active ingredients largely come from China and India, and for many medicines China is the only supplier▶ 0:15:24▶ 0:15:54.

• Price testified Americans lost $17.7 billion to online scams in 2025 (up 29% from 2024), with nearly a quarter of losses hitting citizens over 60▶ 0:36:15▶ 0:36:37.

• Price said scam centers in Myanmar, Cambodia, and Laos generated roughly $44 billion, about 44% of those countries' combined GDP, while China's own scam losses fell 30% as U.S. losses rose 40% in the same year▶ 0:37:04▶ 0:38:28.

• Slevin disclosed that Commission staff spent months trying to obtain data on U.S. exposure to Chinese pharmaceutical inputs and found "nobody has that information," not even the administration or India's government▶ 0:52:32▶ 0:53:02.

• Miller said China's share of global pharmaceutical licensing deals has climbed from 3-5% to over 40% and could reach 70% within a few years, calling it a looming national security issue▶ 1:17:45▶ 1:18:57.

• Gillibrand said the FBI's Internet Crime Complaint Center recorded a jump of nearly 150,000 more complaints from 2024 to 2025 amid $21 billion in cyber-enabled fraud losses▶ 1:06:58▶ 1:07:16.

• Miller warned retirees are often invested in mutual funds holding sanctioned Chinese companies with no transparency, and proposed labeling funds that invest in sanctioned Chinese firms▶ 1:31:28▶ 1:31:48.

• Husted argued the U.S. treated pharmaceuticals as a pure "economics bucket" issue rather than national security for decades, leaving no leverage against China on pharmaceuticals, rare earths, telecom, or shipbuilding▶ 0:55:11▶ 0:56:07.

• Hodges said Chinese components in the U.S. energy grid could allow remote access, posing a potential medical emergency for seniors dependent on dialysis machines or cardiac devices during a power disruption▶ 0:28:34▶ 0:28:55.

• Miller said the credibility of China's threat to cut off pharmaceutical exports doesn't require follow-through — "it just has to be out there" — to shape U.S. decision-making in a crisis▶ 1:13:52▶ 1:14:41.

Metadata

CommitteeSenate Aging (Special)
Chamber / CongressSenate · 119th Congress
DateJune 17, 2026
TypeOpen Hearing
Witnesses
(none listed in event metadata)
Videosenate-isvp
Transcript212 caption blocks · 10,642 words · 1:33:05 runtime
EventCongress.gov 338568